Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells

Blood

Volumn 105, Issue 2, 2005, Pages 576-583

  Chute, John P ^a   Muramoto, Garrett G ^b   Fung, Jennifer ^b   Oxford, Carol ^b  

^a DUKE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; COLONY STIMULATING FACTOR 1; FLT3 LIGAND; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURST FORMING UNIT E; CD34 SELECTION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSPLANTATION; COCULTURE; COLONY FORMING UNIT GM; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 11244252126     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1467     Document Type: Article

References (55)

1. + blood cells. Blood. 1996;87:4903-4909.
2. Civin C, Gore S. Antigenic analysis of hematopoiesis: a review. J Hematother. 1993;93:2217-2224.
3. + cells in cord blood and bone marrow. Blood. 1995;86:3745-3753.
4. Bhatia M, Wang J, Kapp U, et al. Purification of primitive human hematopoietic cells capable of repopulating immune deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
5. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329-1337.
6. Shah A, Smogorzewska, Hannum C, Crooks G. Flt-3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. Blood. 1996;87:3563-3570.
7. Leemhuis T, Yoder M, Grigsby S, Aguero B, Eder P, Srour E. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Exp Hematol. 1999;24:1215-1224.
8. Bhatia M, Bonnet D, Kapp U, et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997;186:619-624.
9. Glimm H, Eaves C. Direct evidence for multiple self-renewal divisions of human in vivo repopulating cells in short-term culture. Blood. 1999;94:2161-2168.
10. Conneally E, Cashman J, Petzer A, et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphoid-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A. 1997;94:9836-9841.
11. + cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93:3736-3749.
12. Tanavde V, Malehorn M, Lumkul R, et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol. 2002;30:816-823.
13. Gan O, Murdoch B, Larochelle A, Dick J. Differential maintenance of human SCID repopopulating cells, clonogenic progenitors, and long term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90:641-650.
14. + cells in non-obese diabetic/severe combined immunodeficient mice. Blood. 1998;92:2641-2649.
15. Chute J, Saini A, Chute D, et al. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood. 2002;100:4433-4439.
16. + cells into the myeloid lineage. Blood. 1992;80:1405-1412.
17. + cells. Blood. 1993;82:3600-3609.
18. low/neg human primitive progenitors exposed to cytokines independent of their mitotic history. Blood. 2001;97:435-441.
19. - cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood. 2000;95:102-110.
20. + cells after ex vivo expansion. Exp Hematol. 2001;29:1465-1473.
21. Mehta K, McQueen T, Manshouri T, Andreeff M, Collins S, Albitar M. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen. Blood. 1997;89:3607-3614.
22. Drach J, McQueen T, Engel H, et al. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Cancer Res. 1994;54:1746-1752.
23. Schulz L, Schweitzer P, Christianson S, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
24. Bonnet D, Bhatia M, Wang J, Kapp U, Dick J. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoetic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 1999;23:203-209.
25. + cells in bone marrow by flow cytometry. J Hematother. 1993;2:305-313.
26. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies, I: data analysis. J Immunol. 1981;126:1614-1619.
27. Wang J, Doedens M, Dick J. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919-3924.
28. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
29. Ishikawa F, Livingston A, Minamiguchi H, Wingard J, Ogawa M. Human cord blood long-term engrafting cells are CD34+CD38-. Leukemia. 2003;17:960-964.
30. Hao Q, Thiemann F, Petersen D, Smogorzewska E, Crooks G. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 1996;88:3306-3313.
31. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 2000;18:1360-1377.
32. Weaver C, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 cell content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961-3969.
33. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expanded UCB cells: results of a phase I trial using the AastromReplicell System. Blood. 2003;101:5061-5067.
34. Gur H, Krauthgamer R, Berrebi A, et al. Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34+ cells. Blood. 2002;99:4174-4181.
35. Piacibello W, Bruno S, Sanavio F, et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Blood. 2002;100:4391-4400.
36. Bailey A, Jiang S, Afentoulis M, et al. Transplanted adult hematopoeitic stem cells differentiate into functional endothelial cells. Blood. 2004;103:13-19.
37. Chute J, Fung J, Muramoto G, Oxford C. Quantitative analysis demonstrates expansion of SCID-repopulating cells (SRC) and increased engraftment capacity within human cord blood cells following culture with human brain endothelial cells. Stem Cells. 2004;22:202-215.
38. Verfaillie C, Catanzaro P. Direct contact with stroma inhibits proliferation of long-term culture initiating cells. Leukemia. 1996;10:498-504.
39. Punzel M, Liu D, Zhang T, et al. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp Hematol. 2003;31:339-347.
40. Kawada H, Ando K, Tsuji T, et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol. 1999;27:904-915.
41. Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood. 2003;101:532-540.
42. Kirito K, Fox N, Kaushansky K. Thrombopoietin stimulates HoxB4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood. 2003;102:3172-3178.
43. Dao M, Hannum C, Kohn D, Nolta J. Flt3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood. 1997;89:446-456.
44. Goff J, Greenberger J. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34+Thy-1 + lin- cells. Blood. 1998;92:4098-4107.
45. Broudy V, Kovach N, Bennett L, Lin N, Jacobsen F, Kidd P. Human umbilical vein endothelial cells display high affinity c-kit receptors and produce a soluble form of c-kit receptor. Blood. 1994;83:2145-2152.
46. Perlingeiro R, Kyba M, Bodie S, Daley G. A role for thrombopoietin in hemangioblast development. Stem Cells. 2003;21:272-280.
47. Brizzi M, Battaglia E, Montrucchio G, et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet activating factor dependent mechanism. Circ Res. 1999;84:785-796.
48. Knobel K, McNally M, Berson A, et al. Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: differential activity of culture bone marrow and enriched stem cell populations. Exp Hematol. 94;22:1227-1235.
49. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075-3085.
50. Bhatia M, Bonnet D, Murdoch B, Gan O, Dick J. A newly discovered class of human hematopoeitic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
51. Gao Z, Fackler MJ, Leung W, et al. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. Exp Hematol. 2001;29:910-921.
52. Terskikh A, Miyomoto T, Chang C, Diatchenko L, Weissman I. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood. 2003;102:94-101.
53. Park I, He Y, Lin F, et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002;99:488-498.
54. Ivanova N, Dimos J, Schaniel C, Hackney J, Moore K, Lemischka I. A stem cell molecular signature. Science. 2002;298:601-604.
55. Oh I, Lau A, Eaves C. During ontogeny primitive (CD34+CD38-) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. Blood. 2000;96:4160-4168.